Lifestance Health Group (LFST) Stock Forecast & Price Target

Compare

212 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

LFST Analyst Ratings

Strong Buy

7 Buy

0 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Lifestance

Health Group

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

LFST Stock 12 Month Forecast

Average Price Target

$9.00

▲(30.25% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Lifestance Health Group in the last 3 months. The average price target is $9.00 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 30.25% change from the last price of $6.91.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","11":"$11","4.25":"$4.25","6.5":"$6.5","8.75":"$8.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,4.25,6.5,8.75,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.41,6.686153846153847,6.962307692307692,7.2384615384615385,7.514615384615385,7.7907692307692304,8.066923076923077,8.343076923076923,8.61923076923077,8.895384615384614,9.17153846153846,9.447692307692307,9.723846153846154,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.41,6.609230769230769,6.808461538461539,7.007692307692308,7.206923076923077,7.406153846153846,7.605384615384615,7.804615384615385,8.003846153846155,8.203076923076923,8.402307692307692,8.60153846153846,8.80076923076923,{"y":9,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.41,6.532307692307692,6.654615384615385,6.776923076923077,6.899230769230769,7.021538461538461,7.1438461538461535,7.266153846153847,7.388461538461539,7.510769230769231,7.633076923076923,7.7553846153846155,7.877692307692308,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.81,"date":1730419200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":7.51,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.37,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.97,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.79,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.63,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.52,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.88,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.79,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.63,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.9,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$10.00

Average Price Target$9.00

Lowest Price Target$8.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Larsen

BTIG

$9→$10

Buy

44.72%

Upside

Reiterated

12/12/25

BTIG Reaffirms Their Buy Rating on Lifestance Health Group (LFST)

Glen Santangelo

Barclays

Buy

15.77%

Upside

Initiated

12/08/25

LifeStance initiated with an Overweight at BarclaysLifeStance initiated with an Overweight at Barclays

Sean Dodge

BMO Capital

Buy

15.77%

Upside

Initiated

11/12/25

LifeStance initiated with an Outperform at BMO CapitalLifeStance initiated with an Outperform at BMO Capital

Richard Close

Canaccord Genuity

Buy

15.77%

Upside

Reiterated

11/07/25

Strong Performance and Promising Outlook: Richard Close Reaffirms Buy Rating for Lifestance Health Group

Kevin Caliendo

UBS

$9→$10

Buy

44.72%

Upside

Reiterated

11/07/25

LifeStance price target raised to $10 from $9 at UBSLifeStance price target raised to $10 from $9 at UBS

Craig Hettenbach

Morgan Stanley

$10

Buy

44.72%

Upside

Reiterated

11/06/25

Positive Outlook for LifeStance Health Group: Overcoming Challenges and Driving Growth with Strategic Initiatives

Ryan Daniels

William Blair

―

Buy

―

Reiterated

11/06/25

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), LENZ Therapeutics (NASDAQ: LENZ) and Lifestance Health Group (NASDAQ: LFST)We also believe these attributes are underappreciated aspects of the model that differentiate LifeStance from industry peers and make the company’s stock a compelling longer-term investment; we reiterate Outperform.

Lisa Gill

J.P. Morgan

Hold

15.77%

Upside

Reiterated

05/28/25

J.P. Morgan Reaffirms Their Hold Rating on Lifestance Health Group (LFST)

Scott Schoenhaus

KeyBanc

Buy

30.25%

Upside

Initiated

04/08/25

Lifestance Health Group (LFST) Receives a New Rating from KeyBanc

Jamie Perse

Goldman Sachs

$10→$11

Buy

59.19%

Upside

Reiterated

02/28/25

Lifestance Health Group (LFST) PT Raised to $11 at Goldman SachsGoldman Sachs analyst Jamie Perse raised the price target on Lifestance Health Group (NASDAQ: LFST) to $11.00 (from $10.00) while maintaining a Buy rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Larsen

BTIG

$9→$10

Buy

44.72%

Upside

Reiterated

12/12/25

BTIG Reaffirms Their Buy Rating on Lifestance Health Group (LFST)

Glen Santangelo

Barclays

Buy

15.77%

Upside

Initiated

12/08/25

LifeStance initiated with an Overweight at BarclaysLifeStance initiated with an Overweight at Barclays

Sean Dodge

BMO Capital

Buy

15.77%

Upside

Initiated

11/12/25

LifeStance initiated with an Outperform at BMO CapitalLifeStance initiated with an Outperform at BMO Capital

Richard Close

Canaccord Genuity

Buy

15.77%

Upside

Reiterated

11/07/25

Strong Performance and Promising Outlook: Richard Close Reaffirms Buy Rating for Lifestance Health Group

Kevin Caliendo

UBS

$9→$10

Buy

44.72%

Upside

Reiterated

11/07/25

LifeStance price target raised to $10 from $9 at UBSLifeStance price target raised to $10 from $9 at UBS

Craig Hettenbach

Morgan Stanley

$10

Buy

44.72%

Upside

Reiterated

11/06/25

Positive Outlook for LifeStance Health Group: Overcoming Challenges and Driving Growth with Strategic Initiatives

Ryan Daniels

William Blair

―

Buy

―

Reiterated

11/06/25

Lisa Gill

J.P. Morgan

Hold

15.77%

Upside

Reiterated

05/28/25

J.P. Morgan Reaffirms Their Hold Rating on Lifestance Health Group (LFST)

Scott Schoenhaus

KeyBanc

Buy

30.25%

Upside

Initiated

04/08/25

Lifestance Health Group (LFST) Receives a New Rating from KeyBanc

Jamie Perse

Goldman Sachs

$10→$11

Buy

59.19%

Upside

Reiterated

02/28/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lifestance Health Group

1 Month

xxx

Success Rate

4/5 ratings generated profit

Average Return

+8.14%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 80.00% of your transactions generating a profit, with an average return of +8.14% per trade.

3 Months

xxx

Success Rate

10/16 ratings generated profit

Average Return

+9.90%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +9.90% per trade.

1 Year

Richard CloseCanaccord Genuity

Success Rate

5/5 ratings generated profit

Average Return

+25.84%

reiterated a buy rating last month

Copying Richard Close's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.84% per trade.

2 Years

xxx

Success Rate

5/5 ratings generated profit

Average Return

+25.84%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +25.84% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LFST Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, LFST has received 9 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. LFST average Analyst price target in the past 3 months is 9.00.

Each month's total comprises the sum of three months' worth of ratings.

LFST Financial Forecast

LFST Earnings Forecast

Next quarter’s earnings estimate for LFST is >-$0.01 with a range of -$0.01 to $0.01. The previous quarter’s EPS was $0.00. LFST beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year LFST has Performed in-line its overall industry.

LFST Sales Forecast

Next quarter’s sales forecast for LFST is $378.04M with a range of $374.30M to $383.57M. The previous quarter’s sales results were $363.81M. LFST beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year LFST has Performed in-line its overall industry.

LFST Stock Forecast FAQ

What is LFST’s average 12-month price target, according to analysts?

Based on analyst ratings, Lifestance Health Group’s 12-month average price target is 9.00.

What is LFST’s upside potential, based on the analysts’ average price target?

Lifestance Health Group has 30.25% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is LFST a Buy, Sell or Hold?

Lifestance Health Group has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.

What is Lifestance Health Group’s price target?

The average price target for Lifestance Health Group is 9.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $8.00. The average price target represents 30.25% Increase from the current price of $6.91.

What do analysts say about Lifestance Health Group?

Lifestance Health Group’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of LFST?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Lifestance Health Group (LFST) Stock Forecast & Price Target

LFST Analyst Ratings

LFST Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Lifestance Health Group

LFST Analyst Recommendation Trends

LFST Financial Forecast

LFST Earnings Forecast

LFST Sales Forecast

LFST Stock Forecast FAQ

Detailed List of Analyst Forecasts